Filing Details

Accession Number:
0000899243-22-006789
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-17 16:30:48
Reporting Period:
2022-02-15
Accepted Time:
2022-02-17 16:30:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1876279 Andrea Sabens C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-15 1,241 $28.64 59,861 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021.